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The loss of body protein that frequently accompanies illness occurs through
changes in protein synthesis and degradation. In human tissues, rates ofprotein
synthesis can be assessed with stable isotopic tracer techniques and mass spec-
trometry. The basic principles of these methods are explained, and the advan-
tages and drawbacks ofthe two main approaches, the constant infusion method
and the flooding method, are described. Examples are given ofthe use of these
methods to investigate protein synthesis and surgical trauma, pathologies ofthe
gastrointestinal tract and the response of tumor growth to amino acid supple-
ments.
INTRODUCTION
Injury and inflammation are frequently accompanied by loss ofprotein from body tis-
sues, and one of the aims of treatment is to minimize this loss and promote its recovery
by nutritional and other therapies. A better understanding of the processes that influence
tissue protein gain and loss can be achieved by studies ofprotein synthesis and degrada-
tion in tissues. These two complex and opposing processes are controlled by a variety of
hormonal, chemical and physical signals, resulting in the maintenance ofprotein balance
in the healthy adult individual. An imbalance resulting from modulation ofeither synthe-
sis or degradation is the cause of protein gain or loss, but in this article we will concen-
trate on measurements of protein synthesis. In particular, we aim to describe techniques
and approaches suitable for in vivo studies in human volunteers and patients.
MEASUREMENT OF PROTEIN SYNTHESIS
Rates ofprotein synthesis have been measured for many years in cells and tissues in
vitro and in animal models using radioactively labeled amino acids. These studies have
made an invaluable contribution to our understanding ofprotein metabolism, but their rel-
evance to human disease can only be assessed by direct measurements in humans. Risk of
radiation limits the use of radioactive isotopes in humans, however, and they have now
been largely replaced by their stable isotope counterparts. The relationships between the
radioactive and stable isotopes of the relevant elements are shown in Table 1. The ones
most commonly used are 13C, 2H and 15N, the latter being important because it is the only
usable isotope of nitrogen, there being no radioactive analogue of practical significance.
In most respects experiments with stable isotopes are the same as those with radioactive
isotopes, except the term "isotopic enrichment" replaces the term "specific radioactivity."
The enrichment is the number oflabeled molecules expressed as a proportion ofthe total
number of molecules ofthe compound, and is measured with a mass spectrometer.
aTo whom allcorrespondence shouldbe addressed: PeterJ. Garlick, Ph.D., Dept. ofSurgery, Health
Sciences Center, T19 020, Stony Brook, NY 11794-8191. Tel.: 516-444-1790; Fax: 516-444-7635;
E-mail: garlick@surg.som.sunysb.edu.
bAbbreviations: GIRMS, gas isotope ratio mass spectrometry; KIC, a-ketoisocaproic acid; TPN,
total parenteral nutrition; GI, gastrointestinal; BCAA, branched chain amino acids; GCMS, gas chro-
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The limitations oftissue sampling in humans and the continual improvement ofmass
spectrometers have resulted in the development of a variety of approaches for measuring
rates of protein synthesis and degradation in the whole body. The label is administered
orally or intravenously, and measurements are made on samples of urine or blood and
breath, which are readily available by relatively non-invasive techniques [1]. Forexample,
Table 1. Stable and radioactive isotopes ofelements commonly used in metabolic research
Element Normal Radioactive Stable
Hydrogen 'H 3H 2H (0.015 percent)
Carbon 12C 14C 13C (1.1 percent)
Nitrogen 14N - 15N (0.37 percent)
Oxygen 160 - 170 (0.037 percent)
180 (0.2 percent)
The "Normal" isotope is the most abundant naturally occurring form. The "Stable" isotopes also
occur naturally, and the average natural abundance is shown in parentheses. "Radioactive" isotopes
are readily available for research for hydrogen and carbon. The radioactive isotopes ofnitrogen and
oxygen have extremely short halflives and can only be used with very special techniques and equip-
ment.
intravenous infusion of[1-13C]leucine for 6-12 hrs results in the attainment ofaplateau in
the enrichment of free leucine in the blood. This plateau value, together with an estimate
of the amount of 13C expired in breath CO2 can then be used to determine the total body
turnover of leucine, and also its origin from dietary intake and body protein degradation
and its disposition into oxidation and body protein synthesis [2, 3, 4]. These techniques
have been used extensively (for reviews see [1, 5, 6]) and have given rise to much useful
information, but suffer from the limitation thatchanges in whole body rates ofprotein syn-
thesis cannot be ascribed with any certainty to any particular organ, tissue or body com-
partment. For example, animal studies have shown that inflammation resulting from sub-
cutaneous injection of turpentine is associated with a fall in protein synthesis in skeletal
muscle, but a rise in the liver [7]. Over the last decade or so, therefore, there has been an
increasing interest in measurements of protein synthesis rates in individual tissues of
human subjects.
The general procedure for measuring tissue protein synthesis in vivo is to inject an
amino acid labeled with the chosen isotope into the bloodstream and to assess its incor-
poration into tissue protein. To determine the rate ofprotein synthesis, two separate mea-
surements must be made. Firstly, a tissue sample is taken at a specific time (t days) after
the isotope is given, and the enrichment of the amino acid in protein (Ep) is measured.
Secondly, the time course ofenrichment ofthe free amino acid precursor ofprotein syn-
thesis over the measurement period must be evaluated, and its average value (Ef) deter-
mined. The rate ofprotein synthesis (ks) is then calculated from the following equation:
ks=Epx 100/Efxt
ks is the fractional rate of protein synthesis, that is the amount of protein synthesized
expressed as a proportion of the amount ofprotein in that tissue.
The amount of label incorporated into protein can not only be measured directly on a
tissue sample, but also it can be inferred from the disappearance of label from the blood
(see Organ Balance Measurement, below). The assessment of the enrichment of the free
amino acid that is being incorporated into protein is more difficult and has given rise to
much debate. Theoretically this measurement should be made on the pool of amino acyl
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Figure 1. Curves illustrating the two main methods ofmeasuring tissue protein synthesis with
labeled amino acids given by constant intravenous infusion (a) and by flooding (b). The lines
represent the time course ofenrichment ofthe free amino acid in theplasma and the tissuepool over
periods of time commonly used with these methods in humans. To determine rates of protein syn-
thesis, a tissue sample is taken at the end of the time period and the enrichment of the amino acid
in protein deterrnined.
tRNA in the tissue, but this is complicated by the extremely rapid rate of turnover of this
pool and its small size, requiring large tissue samples. For most practical purposes the
alternative is to use either the plasma or the tissue (intracellular) free amino acid. As will
be seen below, the isotopic enrichment in these two compartments is not necessarily the
same, which has led to uncertainty in the calculated values for protein synthesis and has
been influential in determining the way in which the labeled amino acid is administered.
Both of the procedures commonly used today were originally suggested by the work of
R.B. Loftfield in the 1950s. When aradioactively labeled amino acid was given to rats by
continuous intravenous infusion, the specific radioactivity in the plasma and tissues rapid-
ly rose to constant (plateau) values, but as illustrated in Figure la, in the tissues the value
remained substantially lower than in the plasma [8]. The interpretation made was that the
intracellular pool was derived partially by transport of amino acid into the cell from the
plasma andpartially from thedegradation ofunlabeledprotein. Moreover, it would be dif-
ficult to calculate rates of protein synthesis with confidence, because it was not known
which, if either, of these two values would be appropriate as the precursor enrichment.
Rates ofprotein synthesis were not therefore calculated, and instead a different method of
label administration was devised, with the aim of making the intra- and extracellular
enrichments the same, thus minimizing the ambiguity. This was achieved by injecting the
labeled amino acid together with a large amount of unlabeled amino acid, sufficiently to
dominate (flood) the small endogenous pool of unlabeled free amino acid [9]. This
approach has become known as the "flooding method"and is illustrated in Figure Ilb. Both
of these approaches have been used extensively in animals with radioactively labeled
amino acids [1, 10]: their use in human subjects will now be described in more detail.
Constant infusion method
The first studies with this method in humans involved measurement of protein syn-
thesis in muscle with [15N]lysine [11] and in GI tissues, including tumors, with
[15N]glycine [12]. Subsequently, the majority of constant infusion studies have used
[I 3C]leucine, which is moderately priced and relatively easily measured [131. Infusions
67Garlick et al.: Human protein synthesis
lasting between 4-12 h are generally primed [13], to achieve plateau labeling more quick-
ly, and are followed by tissue sampling, which in the case ofskeletal muscle, can be done
by percutaneous needle biopsy. The enrichment ofthe amino acid in protein from the tis-
sue biopsy has usually been measured by chromatographic isolation of the leucine from
protein and decarboxylation followed by measurement ofthe enrichment ofthe CO2 pro-
duced by gas isotope ratio mass spectrometry (GIRMS)I.
The precursor enrichment is obtained from serial samples of blood taken during the
infusion. The choice is between free leucine in blood or blood a-ketoisocaproic acid
(KIC), which is the transamination product of leucine and is thought to be representative
ofthe intracellular leucine in skeletal muscle [14]. The KIC enrichment is typically 70-80
percent of that of leucine [14]. It is often thought that the KIC gives the best estimate of
the precursor enrichment, but this remains unproven. The KIC in blood might not be
derived entirely from muscle, and at best it represents an average enrichment for all mus-
cles, which might differ from the enrichment in the single muscle under study [15].
Moreover, there is the possibility that the enrichment ofleucyl tRNA might sometimes be
lower than that ofthe KIC or the intracellular leucine [16, 17]. Although the KIC has been
used for non-muscle tissues such as liver [18], this is not advisable, as there is little rea-
son to suppose that the KIC reflects the liverfree leucine enrichment. Forliver synthesized
proteins (e.g., serum albumin), a far more reliable measure of the precursor enrichment
can be derived from measurements oftheApoB protein ofvery low density lipoprotein in
the blood. As this pool turns over very rapidly, it achieves the same enrichment as its own
precursor within the liver after a few hours ofinfusion [19].
The constant infusion method has been used for many investigations of muscle pro-
tein synthesis in volunteers and patients [20]. Its advantages are that simultaneous mea-
surement can also be made of whole-body protein turnover, and that the labeled amino
acid is given as a tracer, unlike the flooding method, and therefore should not disturb
metabolism. Its disadvantages are the need for a metabolic steady state during the infu-
sion, which might preclude observations when acute metabolic changes are occurring
(e.g., after a meal, in acute illness or during surgery), and the uncertainty regarding the
precursor enrichment.
Constant infusion during limb ororgan balance measurement
Arterio-venous differences in blood amino acid concentrations coupled with mea-
surement of blood flow have often been used to measure the net balance of amino acids
across a limb or organ [21]. When this procedure is performed during a constant infusion
of a labeled amino acid, then rates of protein synthesis and degradation can also be
obtained [22]. In this case, synthesis is not derived from the amount oflabel that appears
in protein of a biopsy, but instead from the amount oflabel thatdisappears from the blood
as itpasses through the tissue. For an amino acid thatis notmetabolized in thetissue under
study, e.g., phenylalanine in muscle, the rate ofuptake oflabel from the blood must equal
the amount incorporated into protein, if the tissue free amino acid pool does not expand
or contract. In other respects, the assumptions are the same as those for the constant infu-
sion method. In particular, a value for the precursor enrichment is needed, and this is usu-
ally taken from the free amino acid in the venous blood.
The major advantage of this method is that a value for protein degradation can also
be obtained, by subtracting the net balance from the rate ofsynthesis. It should be recog-
nized, however, that this is not an independent estimate. If there is any error in synthesis,
eg., arising from the precursor measurement, then the rate of degradation will also be in
error. A recentmodification ofthis techniqueemploys atissuebiopsy at the end ofthe pro-
cedure [23]. This enables the rate of synthesis to be calculated from the intracellular
enrichment, which is useful, as there is no metabolite ofphenylalanine equivalent to KIC
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which can be used as an indicator ofintracellular enrichment. In addition, it is possible to
calculate the rates of transport of the amino acid between the blood and the intracellular
pools.
The balance method can only be done on a tissue or organ with a well defined arter-
ial and venous vasculature. In addition to the disadvantages ofthe infusion method, there
is also the need for arterial catheterization and precise blood flow measurement.
Flooding method
Preliminary experiments showed that intravenous injection of 4 g of [1-13C]leucine
per 80 kg body weight resulted in almostcomplete equalization ofenrichment in the plas-
ma and intracellular pools in muscle of healthy volunteers over a two hour period (illus-
trated in Figure lb, [24]). The rate of muscle protein synthesis is calculated from the
enrichment of leucine in muscle protein at 90 min and the average value for precursor
enrichment, derived from serial measurements on plasma leucine or KIC at intervals
between 0 and 90 min [24]. The value obtained was 1.86 ± 0.12 percent/day when the pre-
cursor was taken to be the plasma leucine and 1.95 ± 0.12 percent/day when the plasma
KIC was used as an index of intracellular labeling [24]. These values are expressed as
fractional rates, in the units of percent per day, which represent the amounts of protein
synthesized as percentages ofthe amount in that tissue.
Although the flooding method successfully equalizes the rates calculated from intra-
cellular and plasmaenrichments, these values are higher than those measured by constant
infusion of [1-3C]leucine, e.g., 1.10 ± 0.07 percent/day [25]. This discrepancy has led to
much debate about the validity of these two methods [10, 20], which is not yet resolved.
There do not appear to be similar discrepancies in tissues of animals such as rats, or in
human tissues other than skeletal muscle [10]. Apparently higher values for colon, liver
and serum albumin synthesis obtained by flooding reported by Rennie et al. [20] can read-
ily be explained. In liver, the longerperiod oflabeling with infusion means that only non-
secretory proteins are measured, whereas total synthesis is measured by flooding [10].
Similarly, with albumin there is turnover ofthe newly synthesized pool in the plasma dur-
ing a long infusion, resulting in an underestimate of the synthesis rate [10]. For both the
colon and the liver, Rennie et al. [20] quote values from patients with pathological condi-
tions (liver protein synthesis in ulcerative colitis patients and protein synthesis in benign
villous adenomas to represent colonic mucosa), in which rates of protein synthesis are
known to be abnormally high [26].
Two possible reasons for the discrepancy in human muscle have been suggested. The
first is the possibility that the enrichment of the precursor amino acid is not being accu-
rately reflected by measurements of plasma leucine or KIC during a constant infusion.
There is evidence that this can occur in cell culture [16], but confirmation that this can
occur in human tissues in vivo is so far lacking (see [10]). If the enrichment at the site of
protein synthesis were lowerthan the KIC, thismightresult in an underestimate ofthe rate
ofsynthesis by constant infusion. Conversely, it has been suggested that the large amount
oflabeled amino acid given during flooding might itselfstimulate muscle protein synthe-
sis, thus giving rise to an artifactually high measured rate by this method [20]. There is no
direct proof that this can occur except from studies using the constant infusion approach
[27], which does not provide independent evidence. Moreover, labeled phenylalanine and
valine both give similar values to that with leucine, when given in flooding amounts, and
injection of leucine does not alter the distribution ofpolyribosomes in muscle [28].
The advantages of infusion are that the label is given as a true tracer, which does not
alter metabolism, and measurements of whole body protein turnover can be made simul-
taneously. The disadvantage is the ambiguity regarding the precursor enrichment and the
need to establish a metabolic steady state in order to maintain plateau labeling of free
6970 Garlick et al.: Humanprotein synthesis
SO - _
X..
Figure 2. Fractional rates of proteiln synthesis in a range of healthy human tissues.
Measurements were made by flooding with either [1I-'3C]leucine or[2H5]phenylalanine, and values
are fractions of the tissue protein renewed each day by synthesis (percent/d). Data taken from: [10,
24, 26, 35].
amino acid pools. We prefer the flooding method because it is of short duration (typical-
ly 45-90 min), so is suitable for observing acute changes, it is not dependent on a meta-
bolic steady state, so is suitable for studies in the perioperative period, and minimizes
problems ofprecursor measurement. The potential disadvantage is the lack ofdirect proof
that protein synthesis is not altered by the "flood." Both methods have been used to inves-
tigate the control ofprotein synthesis in a variety ofhuman tissues. Figure 2 illustrates the
wide range of fractional rates ofsynthesis observed in various healthy tissues taken from
volunteers and from patients during surgery. The remainder of this article will be devoted
to examples of measurements ofprotein synthesis by the flooding method in human sub-
jects in a range of metabolic and clinical states.
MUSCLE PROTEIN SYNTHESIS AND SURGICAL TRAUMA
In an attempt to elucidate the muscle wasting that takes place after surgical injury,
measurements of muscle protein synthesis were made in cholecystectomy patients before
and after surgery. A short period of anesthesia without surgery did not affect muscle pro-
tein synthesis, butimmediately after the completion ofsurgery, there was already a 30 per-
cent fall [29]. By day 3 after surgery, the decrease in protein synthesis had enlarged to 50
percent [30]. These data suggest that muscle wasting after surgery results at least in part
from an immediate and sustained decrease in muscle protein synthesis. Further experi-
ments were performed to see whether this change was dependent on the degree oftrauma,
and whether it could be modified by strategies designed to alleviate the wasting. Minor
surgery for breast lump removal did not affect muscle protein synthesis [31]. Surprisingly,Garlick et al.: Human protein synthesis
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Figure 3. The response of muscle protein synthesis to surgery (cholecystectomy) by the con-
ventional (open) technique and by laparoscopy. The rate of protein synthesis was measured by
injection of a flooding amount of [2H5]phenylalanine on two occasions in each patient: before
surgery and one day after surgery. Data from [32].
laparoscopic surgery did not produce a smaller response than conventional, open surgery
(Figure 3), even though its beneficial effects on recovery are well accepted [32].
Moreover, postoperative total parenteral nutrition (TPN) did not diminish the decrease in
protein synthesis [30]. These results suggest that new strategies, such as provision ofglu-
tamine in TPN [33], or treatment with growth hormone [34], might be needed to minimize
protein loss after surgery and optimize recovery.
PATHOLOGIES OF THE GASTROINTESTINAL TRACT
The GI tract is accessible to study during surgery orendoscopy. Rates ofprotein syn-
thesis in mucosa of the esophagus, stomach and colon are several fold higher than that in
muscle, consistent with the rapid rate ofcell proliferation and protein secretion of mucos-
al tissue (Figure 2). Samples of inflamed colonic mucosa taken during surgery for ulcer-
ative colitis showed much higher rates ofprotein synthesis than those in healthy mucosa
(24.7 ± 2.5 percent/d, vs 9.4 ± 1.2 percent/d) [26], probably as a result of increased cell
turnover and mucous synthesis. However, the inflammation in the colon is also accompa-
nied by systemic changes, as shown by a 50 percent stimulation ofprotein synthesis in the
liver (35.4 ± 2.3 percentld vs 20.7 ± 1.9 percent/d) [26]. This result in humans is consis-
tent with information obtained in animal models of inflammation, such as subcutaneous
injection ofturpentine or interleukin-lB [7], and might result in part from a stimulation of
acute-phase proteins synthesis.
Other diseases of the GI mucosa also lead to alterations in protein synthesis. The
columnar lined esophagus ofBarrett's disease has been shown to have a lower rate of pro-
tein synthesis than adjacent squamous mucosa [35], in line with the reported lower rate of
cell proliferation of the columnar cells [36]. By contrast, both malignant and benign
tumors of the colon have rates of protein synthesis that are much higher than in normal
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healthy colonic mucosa [26]. Not only do these tumors have high rates of mucous pro-
duction, but they have high rates ofcell proliferation and net growth. It has therefore been
suggested that tumor protein synthesis might be used as an index of changes in tumor
growth rate [37, 38]. Moreover, in tumor cells in culture, changes in cell growth are
accompanied by changes in protein synthesis in the same direction [39-41]. This has led
us to a series ofexperiments on the effects ofamino acids on the growth ofhuman tumors
in vivo.
AMINO ACIDS AND TUMOR GROWTH
The question ofwhether feeding ofthe host stimulates the growth ofthe tumor led to
measurements ofprotein synthesis in colorectal tumors offasted and fed patients. During
the 24 hrs prior to surgery, patients were either totally fasted or were given intravenous
nutrition. [1-13C]Leucine was injected just before induction of anesthesia and a small
sample of tumor was taken. The rate of protein synthesis was 80 percent higher in the
patients given TPN [42], suggesting that the tumor was indeed sensitive to the supply of
nutrients. However, when the TPN containing a standard mixture of amino acids was
replaced with one containing a higher proportion ofbranched chain amino acids (BCAA)
the stimulation of tumor protein synthesis was significantly diminished [43]. BCAA sup-
plementation had previously been suggested to be beneficial to cancer patients, because it
was shown to enhance whole-body protein synthesis [44]. However, in the experiment on
colorectal cancer patients, the rate of protein synthesis in skeletal muscle was also lower
in the BCAA supplemented group [43], suggesting that the BCAA did not favor host tis-
sue metabolism over tumor growth.
The amino acid arginine has been studied extensively for its potentially beneficial
effects on immunity, recovery from surgery, wound healing, and specifically on tumor
growth [45]. An inhibitory effect ofarginine supplementation on the growth oftumor cells
in culture and in animal models of cancer has been reported in a variety of studies [45],
but this effect is paradoxical, as in other studies a stimulation oftumor growth by arginine
was demonstrated [46, 47]. However, none of these observations were made in human
cancer patients. We therefore made measurements of tumor protein synthesis in breast
cancer patients who had taken arginine supplements (30 g/d for 3 days) prior to surgery,
compared with patients receiving no supplements [48]. The result is given in Table 2,
showing that the arginine supplements, rather than inhibiting the tumor, actually stimulat-
ed. This implies that arginine supplementation ofcancer patients cannot be used to inhib-
it the tumor, and might in fact enhance tumor growth. It reveals the need for more infor-
mation on arginine's effects on human tissues, before its potential forbenefit in cancer and
other diseases can be realized. Preliminary studies on a different human cancer, squamous
Table 2.
Tlumor type Protein synthesis (percent/d ± sem)
Control Arginine
Breast 10.0 ± 1.2 22.6 ± 2.7*
Head/neck 23.9 ± 2.0 20.8 ± 2.4
Effect ofdietary arginine supplements on rates ofprotein synthesis in two different human tumors.
Patients were given dietary arginine supplements (30 g/d) for three days prior to surgery, and con-
trols were given no supplement. At surgery rates of protein synthesis in the tumor were measured
by injection of a flooding amount of[1-13C]leucine (breast) or[2H5]phenylalanine (head and neck),
followed by removal ofa tumor sample for assessment ofthe incorporation oflabel. *p < .005. Data
from [48, 49].
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tumors of the head and neck, have shown that the stimulation by arginine is not common
to all tumor types. As Table 2 shows, these tumors not are stimulated by arginine supple-
ments in the same way as the breast tumors [49], giving hope that arginine might be of
value in some types of cancer.
In the two studies described above, tentative conclusions regarding the effects of
nutrients on tumor growth were made from changes in tumor protein synthesis. This mea-
surement has the advantage that it can be performed in vivo in the cancerpatient, in whom
direct measurement oftumor growth is not usually possible, thus reducing the need to rely
on evidence extrapolated from animal models to humans. Additional validation of this
procedure was provided in the above studies by measurements of the expression of cell
proliferation indices. The response of colorectal tumors to feeding with conventional or
BCAA supplemented amino acids was the same when assessed by measurement of pro-
liferating cell nuclear antigen [43]. Moreover, the stimulation ofprotein synthesis in breast
tumors by arginine was also apparent as a large increase in the expression of Ki67 [48],
another marker ofcell proliferation. Measurement oftumor protein synthesis might there-
fore be a useful tool for evaluating the factors that determine human tumor growth.
CONCLUSIONS
These examples illustrate the range of studies of protein synthesis that can now be
performed in human volunteers and patients. Until recently, these studies were somewhat
limited by the need for large (-200 mg) tissues samples, to enable the enrichment in pro-
tein to be measured by gas isotope ratio mass spectrometry (GIRMS). This also made the
analysis very expensive, as an additional instrument, a gas chromatography mass spec-
trometer (GCMS), was needed to measure the free amino acid enrichment. However, new
advances in mass spectrometry have enabled these measurements to be made on tissue
biopsies as small as 1 mg. We have been able to modify the GCMS procedure for the mul-
tiply labeled amino acid, [2H5]phenylalanine, to enable very low enrichments such as
those found in muscle protein to be measured [50]. This method is proving very useful, as
it is very sensitive, requires a relatively low cost GCMS instrument which can also mea-
sure the free amino acid enrichments, and involves much simpler preparation for analysis
than the GIRMS procedure for [1-13C]leucine. The GIRMS method has also been modi-
fied to achieve better sensitivity and ease of use by interfacing with a gas chromatograph
and combustion furnace [51]. These improvements will greatly expand the range of tis-
sues that can be studied and will enable measurements to be made on isolated cells and
purified proteins from humans, reducing the need to rely on experimental animal models,
and leading to a better understanding of the pathophysiology of human illness and nutri-
tion.
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